Stay updated on Azacitidine and Pembrolizumab in MDS Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.

Latest updates to the Azacitidine and Pembrolizumab in MDS Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedUI labels and navigation elements have been updated on the study details page, including new sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and the 'Intervention/Treatment' heading with an updated revision footnote. Additionally, new metadata labels 'Last verified' and 'Last known status was' were added.SummaryDifference2%

- Check17 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor version update. This change does not alter the study content or details.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page now displays Revision: v3.5.4, indicating an updated version of the page content and replacing the previous Revision: v3.5.3.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page shows a new revision version (v3.5.3) replacing the previous v3.5.2, indicating a small update to the page content or metadata. This change updates the revision history but does not alter substantive study information.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to study content or page functionality.SummaryDifference0.1%

Stay in the know with updates to Azacitidine and Pembrolizumab in MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.